- Home
- SHIP vs PLYX Comparison
SHIP vs PLYX Comparison
Compare SHIP & PLYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SHIP | PLYX |
|---|---|---|
| Founded | 2008 | 2014 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 287.6M | 262.3M |
| IPO Year | 2008 | N/A |
Fundamental Metrics
Financial Performance| Metric | SHIP | PLYX |
|---|---|---|
| Price | $13.15 | $5.75 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $17.00 | $10.00 |
| AVG Volume (30 Days) | 289.8K | ★ 2.0M |
| Earning Date | 02-17-2026 | 01-01-0001 |
| Dividend Yield | ★ 3.55% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $25.33 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $13.34 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.79 | $2.20 |
| 52 Week High | $14.93 | $8.15 |
Technical Indicators
Market Signals| Indicator | SHIP | PLYX |
|---|---|---|
| Relative Strength Index (RSI) | 54.41 | 54.18 |
| Support Level | $7.85 | $2.37 |
| Resistance Level | $14.93 | $7.43 |
| Average True Range (ATR) | 0.61 | 1.16 |
| MACD | -0.19 | 0.19 |
| Stochastic Oscillator | 44.59 | 64.59 |
Price Performance
Historical ComparisonAbout SHIP Seanergy Maritime Holdings Corp.
Seanergy Maritime Holdings Corp is an international shipping company that provides marine dry bulk transportation services through the ownership and operation of dry bulk vessels. It generates a majority of its revenue from the vessels. The company's fleet of vessels includes Blueship, Meiship, Kaizenship, Iconship, Titanship, Flagship, Paroship, Worldship, Hellasship, Partnership, Championship, Patriotship, Dukeship, Honorship, Fellowship, Knightship, Lordship, Premiership, Squireship, and Friendship.
About PLYX Polaryx Therapeutics Inc. Common Stock
Polaryx Therapeutics Inc is a clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric LSDs. Its therapeutic approach focuses on treating the underlying pathophysiology of these diseases and addressing unmet needs. The company's therapeutic pipeline includes PLX-200, PLX-300, and PLX-100, which are orally available small molecule drug candidates designed to address core pathological mechanisms common to LSDs.